Evidence map›Paper›PMID 25008862›Full record

ArticleGenes and immunity2014

Identification of functional, short-lived isoform of linker for activation of T cells (LAT).

M Kłossowicz, K Marek-Bukowiec, M M Arbulo-Echevarria, B Ścirka, M Majkowski, A F Sikorski, E Aguado, A Miazek

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Increased Protein Stability and Interleukin-2 Production of a LATFrontiers in cell and developmental biology · 2020
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

M KłossowiczLaboratory of Tumor Immunology, Department of Tumor Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
K Marek-BukowiecLaboratory of Tumor Immunology, Department of Tumor Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
M M Arbulo-EchevarriaDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cadiz and Puerto Real University Hospital Research Unit, School of Medicine, Department of Biomedicine, Biotechnology and Public Health (Immunology), Cadiz, Spain.
B ŚcirkaLaboratory of Tumor Immunology, Department of Tumor Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.
M MajkowskiLaboratory of Cytobiochemistry, Biotechnology Faculty, University of Wrocław, Wroclaw, Poland.
A F SikorskiLaboratory of Cytobiochemistry, Biotechnology Faculty, University of Wrocław, Wroclaw, Poland.
E AguadoDepartment of Biomedicine, Biotechnology and Public Health (Immunology), Core Research Facility for Health Sciences, University of Cadiz and Puerto Real University Hospital Research Unit, School of Medicine, Department of Biomedicine, Biotechnology and Public Health (Immunology), Cadiz, Spain.
A Miazek1] Laboratory of Tumor Immunology, Department of Tumor Immunology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland [2] Department of Biochemistry, Pharmacology and Toxicology, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
Polish Academy of Sciences · PLUniversidad de Cádiz · ESUniversity of Wrocław · PLLudwik Hirszfeld Institute of Immunology and Experimental Therapy · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linker for activation of T cells (LAT) is a transmembrane adaptor protein playing a key role in the development, activation and maintenance of peripheral homeostasis of T cells. In this study we identified a functional isoform of LAT. It originates from an intron 6 retention event generating an in-frame splice variant of LAT mRNA denoted as LATi6. Comparison of LATi6 expression in peripheral blood leukocytes of human and several other mammalian species revealed that it varied from being virtually absent in the mouse to being predominant in the cow. Analysis of LAT isoform frequency expressed from minigene splicing reporters carrying loss- or gain-of-function point mutations within intronic polyguanine sequences showed that these elements are critical for controlling the intron 6 removal. The protein product of LATi6 isoform (LATi6) ectopically expressed in LAT-deficient JCam 2.5 cell line localized correctly to subcellular compartments and supported T-cell receptor signaling but differed from the canonical LAT protein by displaying a shorter half-life and mediating an increased interleukin-2 secretion upon prolonged CD3/CD28 crosslinking. Altogether, our data suggest that the appearance of LATi6 isoform is an evolutionary innovation that may contribute to a more efficient proofreading control of effector T-cell response.

Indexed as

Alternative SplicingAdaptor Proteins, Signal TransducingAnimalsBase SequenceCell LineHumansIntronsLeukocytesMembrane ProteinsMiceMolecular Sequence DataPoint MutationPoly GProtein IsoformsProtein StabilityProtein TransportAdaptor Proteins, Signal TransducingLAT protein, humanMembrane ProteinsPoly GProtein IsoformsRNA, Messenger

Identifiers

PMID25008862
OpenAlexW1992621568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.